Intermediate
|
Structure
|
CAS No.
|
Usage
|
3-Ethynylailine
|
![]() |
54060-30-9
|
Erlotinib
|
|
1,2,3-tri-O-acetyl-5-deoxy ribofuranose
|
![]() |
62211-93-2
|
Capecitabine
|
|
2-deoxy-2,2-difluoro-d-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate
|
![]() |
122111-11-9
|
Gemcitabine Hydrochloride
|
|
2-Deoxy-2,2-difluoropentofuranos-1-ulose-3,5-dibenzoate
|
![]() |
122111-01-7
|
Gemcitabine Hydrochloride
|
|
4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile
|
![]() |
675126-26-8
|
Gefitinib
|
|
4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol
|
![]() |
184475-71-6
|
Gefitinib
|
|
4-(3-chloro-4-fluorophenylamino)-6-Acetoxy -7-methoxyquinazoline
|
![]() |
184475-70-5
|
Gefitinib
|
|
6-Acetoxy-4-chloro-7-methoxyquinazoline
|
![]() |
230955-75-6
|
Gefitinib
|
|
(3R,4S)-3-(1-Ethoxyethoxy)-4-(phenyl)-N-Benzoyl-2-Azetidinone
|
![]() |
201856-53-3
|
Paclitaxel
|
|
6-hydroxy-7-methoxyquinazolin-4(3H)-one
|
![]() |
179688-52-9
|
Gefitinib
|
|
(3R,4S)-3-Hydroxy-4-phenyl-2-azetidinone
|
![]() |
132127-34-5
|
Paclitaxel
|
|
6,7-Bis(2-Methoxyethoxy) -4-Chloro-Quinazoline
|
![]() |
183377-18-1
|
Erlotinib
|
|
6,7-Bis(2-Methoxyethoxy) -4-(3H)-Quinazoline
|
![]() |
179688-29-0
|
Erlotinib
|
|
4,6-Dichloro-2-methylpyrimidine
|
![]() |
1780-26-3
|
Dasatinib
|
|
2-amino-n-(2-chloro-6-methylphenyl)thiazole-5-carboxamide
|
![]() |
302964-24-5
|
Dasatinib
|
|
4-[(4-Methyl-1-piperazinyl)methyl]-benzoic acid dihydrochloride
|
![]() |
106261-49-8
|
Imatinib Mesylate
|
|
4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine
|
![]() |
152460-10-1
|
Imatinib Mesylate
|
|
2',3'-di-O-acetyl-5'deoxy-5-fluorocytidine
|
![]() |
161599-46-8
|
Capecitabine
|
|
3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate
|
![]() |
179688-53-0
|
Gefitinib
|
|
Methyl-2,3-isopropylidene-5-o-p- toluene sulfonyl-b-D-ribofuranoside
|
![]() |
13007-50-6
|
Capecitabine
|
|
(1S,2S,3R,5S)-Pinanediol L-phenylalanine-L-leucine boronate, HCl salt
|
![]() |
N/A
|
Bortezomid
|
|
(1R)-(S)- Pinanediol 1-ammonium trifluoroacetate-3-mrthylbutane-1-boronate
|
![]() |
179324-87-9
|
Bortezomid
|
|
Calcium folinate
|
![]() |
1492-18-8
|
Calcium
|
|
5-Amino-1-(N-methylcarbamoyl) imidazole-4-carboxamide
|
![]() |
188612-53-5
|
Temozolomide
|
|
3-Aminopiperidine-2,6-dione hydrochloride
|
![]() |
24666-56-6
|
Lenalidomide
|
|
Methyl 2-bromomethyl-3-nitrobenzoate
|
![]() |
98475-07-1
|
Lenalidomide
|
|
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt
|
![]() |
137281-23-3
|
Pemetrexed disodium
|
|
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
|
![]() |
134790-39-9
|
Gemcitabine Hydrochloride
|
|
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester 4-methylbenzenesulfonate
|
![]() |
165049-28-5
|
Pemetrexed disodium
|
|
Bortezomib Intermediate
|
![]() |
N/A
|
Bortezomid
|
|
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester
|
![]() |
146943-43-3
|
Pemetrexed disodium
|
|
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic acid
|
![]() |
137281-39-1
|
Pemetrexed disodium
|
|
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid methyl ester
|
![]() |
155405-80-4
|
Pemetrexed disodium
|
|
(3R,4S)-tert-Butyl 2-oxo-4-phenyl-3-(triethylsilyloxy)azetidine-1-carboxylate
|
![]() |
149198-47-0
|
Cabazitaxel
|
|
Benzeneprpanoic acid,β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-
|
![]() |
114915-14-9
|
Docetaxel
|
|
2-Azetidinone,4-phenyl-3-[(triethylsilyl)oxy]-, (3R,4S)-
|
![]() |
149140-54-5
|
Docetaxel
|
|
(3R,4S)-1-Benzoyl-4-phenyl-3-[(triethylsilyl)oxy]-2-azetidinone
|
![]() |
149249-91-2
|
Paclitaxel
|
|
Methyl-5-deoxy-2,3-O-isopropylidene-beta-D-ribofuranoside
|
![]() |
23202-81-5
|
Capecitabine
|